Cargando…
Synthetic Epigenetic Reprogramming of Mesenchymal to Epithelial States Using the CRISPR/dCas9 Platform in Triple Negative Breast Cancer
Epithelial‐mesenchymal transition (EMT) is a reversible transcriptional program invoked by cancer cells to drive cancer progression. Transcription factor ZEB1 is a master regulator of EMT, driving disease recurrence in poor‐outcome triple negative breast cancers (TNBCs). Here, this work silences ZEB...
Autores principales: | Waryah, Charlene, Cursons, Joseph, Foroutan, Momeneh, Pflueger, Christian, Wang, Edina, Molania, Ramyar, Woodward, Eleanor, Sorolla, Anabel, Wallis, Christopher, Moses, Colette, Glas, Irina, Magalhães, Leandro, Thompson, Erik W., Fearnley, Liam G., Chaffer, Christine L., Davis, Melissa, Papenfuss, Anthony T., Redfern, Andrew, Lister, Ryan, Esteller, Manel, Blancafort, Pilar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401103/ https://www.ncbi.nlm.nih.gov/pubmed/37217832 http://dx.doi.org/10.1002/advs.202301802 |
Ejemplares similares
-
Epigenetic reactivation of tumor suppressor genes with CRISPRa technologies as precision therapy for hepatocellular carcinoma
por: Sgro, Agustin, et al.
Publicado: (2023) -
Activating PTEN Tumor Suppressor Expression with the CRISPR/dCas9 System
por: Moses, Colette, et al.
Publicado: (2018) -
Removing unwanted variation from large-scale RNA sequencing data with PRPS
por: Molania, Ramyar, et al.
Publicado: (2022) -
Precision medicine by designer interference peptides: applications in oncology and molecular therapeutics
por: Sorolla, Anabel, et al.
Publicado: (2019) -
Tumour suppression by targeted intravenous non-viral CRISPRa using dendritic polymers
por: Kretzmann, Jessica A., et al.
Publicado: (2019)